Searched for
COMMERCIALISATION OF SCIENTIFIC DISCOVERY
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
Aatmanirbhar Bharat: Science of patience, scale, collabIndia is poised to become an innovation nation. New initiatives like RDIF and ANRF support deep technologies. Universities and labs are key...
Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...
Cabinet nod for Biomedical Research Career Programme Phase-IIIGovernment approved Biomedical Research Career Programme Phase III. This program will train over 2,000 students and fellows. It aims to gen...
India led science for 2,000 years, but can it lead in AI and Quantum? Myntra founder Mukesh Bansal weighs inIndia once led the world in science and mathematics, but today it lags behind in cutting-edge technology. Myntra co-founder Mukesh Bansal h...
‘One Patent A Day’ drives research at IIT-MadrasThe professor was speaking at the institute’s Gopalakrishnan-Deshpande Centre for Innovation and Entrepreneurship (GDC) Fifth Annual Sympos...
A reformative step throws open Indian defence, aerospace to ingenuity and enterpriseTo create pathways for facilitating accelerated acquisition of military grade solutions developed and qualified through iDEX, the Defence A...
Lupin developing new products to treat cancer, other diseasesSharing details, Kamboj said the the Mumbai-based company is currently working on developing various products, including two major ones to ...
- CSIR'S anti-diabetic drug: Did it deserve Modi's praise?
Bengaluru, Oct 2 (IANS) Lauding the achievements of the Council of Scientific and Industrial Research (CSIR) on its platinum jubilee earlie...
Scientists turn entrepreneurs, take research from labs to marketEvolution of scientific start-ups in India needs public-private partnership, easier norms, patient capital and funds for early-stage ventur...
Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
Cadila Pharma, Helperby sign licensing deal on antibiotic drug resistanceDescribed as the most important innovation in the discovery of antibiotics since Alexander Fleming's original breakthrough more than 80 yea...
Cadila Pharmaceuticals Ltd & Helperby sign licensing deal on antibiotic drug resistanceHelperby will supply Cadila Pharma with Antibiotic Resistance Breakers whilst Cadila will develop the combinations with old antibiotics.
- Indian wins US cash grant for cancer treatment device
Cytotron, a therapeutic device to treat cancer, has been awarded a cash grant of a quarter million dollars by the US government.
- Ranbaxy to start clinical trials of anti-inflammatory molecule soon
Ranbaxy and UK major Glaxosmithkline (GSK) plan to begin clinical trials of an anti-inflammatory molecule by the end of the year.
'Give scientists enough freedom'Researchers attached to institutions like Royal Society of the UK, Imperial College of London and various Indian universities will have an ...
- TCG LifeSc, Forest Lab in drug discovery pact
TCG Lifesciences on Monday said it has entered into a pact with the US-based Forest Laboratories for drug discovery to treat inflammatory d...
- Indian pharma cos close to blockbuster breakthrough
Indian pharma majors may manage to market their first indi-genous "blockbuster drugs" or new chemical entities (NCEs) in the next four year...
- Innovation to drive India, US ties
This is a serious effort to build scientific and technological cooperation between India and the USA.